Based in the United Kingdom, Bitrobius is a startup. Brouky records 1 investor associated with the company.
Bitrobius develops Gentrafix™, a gene therapy technology that delivers DNA plasmids capable of replicating and spreading corrected genes to treat genetic diseases, including mitochondrial disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.